Solid self-microemulsifying drug delivery systems in modern pharmaceutics: design, characterization, and clinical applications
DOI:
https://doi.org/10.69857/joapr.v14i4.2413Keywords:
Solid SMEDDS, Oral bioavailability, BCS Class II, Lipid-based drug delivery, Supersaturable SMEDDS, Lymphatic transport, Solid self-microemulsifying drug delivery systems, oral bioavailability, Biopharmaceutics Classification System Class II, lipid-based drug delivery, supersaturable formulations, lymphatic transportAbstract
Background: Approximately 40% of marketed medicines and 70% of pipeline products exhibit poor aqueous solubility, leading to inconsistent oral bioavailability and impaired efficacy. S-SMEDDS represent a revolutionary approach for converting liquids into stable solid dosage forms. Methodology: Methods employed to prepare S-SMEDDs include adsorption onto carriers, spray drying, hot-melt extrusion, and freeze-drying. Characterization includes assessing self-emulsifying behavior, dynamic light scattering, powder diffraction, and thermal analysis. Results and Discussion: Depending on the drug's characteristics, the formulation composition, and the study conditions, S-SMEDDS can increase bioavailability by two to ten times. However, for some extremely lipophilic BCS Class II and IV pharmaceuticals, significantly greater benefits (up to ~50-fold) have been documented. Several investigations have demonstrated that S-SMEDDS exhibit better physical and chemical stability than liquid systems under ICH Q1A(R2) accelerated storage conditions due to reduced lipid mobility and a lower risk of phase separation. Applications extend to the treatment of cardiovascular, oncological, and endocrine disorders with improved pharmacodynamic efficacy. The multiple absorption mechanisms in S-SMEDDS include improved solubilization, reduced precipitation, lymphotropic delivery, and inhibition of efflux pumps. They demonstrate higher chemical and physical stability, precise dosing, and better patient adherence when compared to traditional liquid counterparts. Conclusion: S-SMEDDS constitute an established pharmaceutical platform that overcomes the drawbacks associated with liquid lipid drug delivery systems. Their high effectiveness, manufacturability, and compatibility with novel technologies such as three-dimensional printing and artificial intelligence position them to be the foundation for precision oral drug delivery.
Downloads
References
Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front. Pharmacol. 12, 618411 (2021) https://doi.org/10.3389/fphar.2021.618411
de O. Macedo L, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: Factors that influence pharmacokinetics. Pharmaceutics. 16, 1141 (2024) https://doi.org/10.3390/pharmaceutics16091141
Onoue S, Yamada K, Sato H. Advanced oral drug delivery systems: Current challenges and emerging technologies. Acta Pharm. Sin. B (2025) https://doi.org/10.1016/j.apsb.2025.11.036
Srivastav AK, Karpathak S, Rai MK, Kumar D, Misra DP, Agarwal V. Lipid based drug delivery systems for oral, transdermal and parenteral delivery: Recent strategies for targeted delivery consistent with different clinical application. J. Drug Deliv. Sci. Technol. 104526 (2023) https://doi.org/10.1016/j.jddst.2023.104526
Kanoujia K, et al. Self microemulsifying drug delivery system (SMEDDS): A novel approach to improve the therapeutic efficacy of orally administered drug. Res. J. Pharm. Dosage Forms Technol. 10, 95–100 (2018) https://doi.org/10.5958/0975-4377.2018.00015.0
Kumar M, Chawla PA, Faruk A, Chawla V. Design and evaluation of solid self-nanoemulsifying drug delivery systems of cyclosporine developed with a superior adsorbent base. RSC Pharm. 2, 318–332 (2024) https://doi.org/10.1039/d4pm00198b
Uttreja P, et al. Self-emulsifying drug delivery systems (SEDDS): Transition from liquid to solid—A comprehensive review of formulation, characterization, applications, and future trends. Pharmaceutics. 17, 63 (2025) https://doi.org/10.3390/pharmaceutics17010063
Palomero-Hernández FJ, Caballo-González MÁ, de la Mata FJ, García-Gallego S. Sustainable shell formulations as alternative to the conventional soft gelatin capsules in pharmaceutical and nutraceutical applications: A review. Macromol. Mater. Eng. (2025) https://doi.org/10.1002/mame.202500003
de Sousa Borges O, et al. From liquid to solid: Formulation and characterization of testosterone-loaded S-SMEDDS pellets using a 2⁴ factorial design. AAPS PharmSciTech. 27, 329 (2026) https://doi.org/10.1208/s12249-026-03329-2
Bhatt J, Dhyani A, Kukreti G, Durgapal S, Kumar G. Self-emulsifying drug delivery systems as a paradigm for enhancing bioavailability of phytoconstituents. J. Solution Chem. (2026) https://doi.org/10.1007/s10953-026-01564-6
Hsieh CM, Yang TL, Putri AD, Chen CT. Application of design of experiments in the development of self-microemulsifying drug delivery systems. Pharmaceutics. 15, 283 (2023) https://doi.org/10.3390/ph16020283
Adhav MS, Yadav DV, Borade MG, Jadhav A. Self-nanoemulsifying drug delivery system: Formulation, characterization and solidification approaches. J. Drug Deliv. Ther. 16, 289–296 (2026) https://doi.org/10.22270/jddt.v16i3.7597
Yang K, Wang Y, Wei Z, Zhu Y, Duan Z. Physical and chemical properties of commercial medium- and long-carbon-chain triglyceride products: Triglyceride composition, volatile substances, thermodynamic properties. J. Sci. Food Agric. (2026) https://doi.org/10.1002/jsfa.70449
Collins K, et al. The gut microbiome modulates the lipase-mediated digestion of dietary lipid emulsions. Colloids Surf. B Biointerfaces. 265, 115715 (2026) https://doi.org/10.1016/j.colsurfb.2026.115715
Liu C, et al. Development and evaluation of a phospholipid complex-loaded SMEDDS for enhanced oral delivery of H007, a novel anti-hyperlipidemic drug. Pharmaceutics. 18, 474 (2026) https://doi.org/10.3390/pharmaceutics18040474
Bakhle S, Biswas R, Upadhye K, Dixit G, Mangrulkar S, Shah P. Rosuvastatin-loaded solid SMEDDS: An innovative approach for solubility augmentation and improved pharmacodynamic profile. J. Dispers. Sci. Technol. 46, 669–683 (2025) https://doi.org/10.1080/01932691.2023.2299750
Dangre P, Yadav D, Jain P, Butle S, Shirode P, Chalikwar S. Powder characterization and flow investigation using SeDeM-SLA of solid SMEDDS of fimasartan. Powder Technol. 470, 122012 (2026) https://doi.org/10.1016/j.powtec.2025.122012
Shivaraj D, Bellaiah PGB, Srinivasa S. Development and characterization of olmesartan medoxomil self-microemulsifying fast disintegrating tablet. J. Drug Deliv. Ther. 15, 89–97 (2025) https://doi.org/10.22270/jddt.v15i4.7090
Baghel P, Roy A, Verma S, Satapathy T, Bahadur S. Enhancement of solubility of paclitaxel by applying factorial design. Curr. Med. Res. Pract. 11, 216 (2021) https://doi.org/10.4103/cmrp.cmrp_51_20
Zhang H, et al. Current status and future prospects on nanodelivery systems targeting the small intestine for absorption of bioactive substances. Foods. 14, 3234 (2025) https://doi.org/10.3390/foods14183234
Steyn JD, et al. Evaluation of drug permeation enhancement by using in vitro and ex vivo models. Pharmaceutics. 17, 195 (2025) https://doi.org/10.3390/ph18020195
Yu J, et al. Recent advances in oral drug delivery systems for BCS III drugs. Curr. Issues Mol. Biol. 48, 63 (2026) https://doi.org/10.3390/cimb48010063
Haddadzadegan S, Summonte S, Ricci F, Sandmeier M, Bernkop-Schnürch A. Intraoral drug delivery: Bridging the gap between academic research and industrial innovations. Adv. Funct. Mater. (2025) https://doi.org/10.1002/adfm.202500157
Kashmar SA, Abou Assi R, Alhijjaj M, Chan SY. Development and validation of a simultaneous HPLC stability-indicating method for atorvastatin and apigenin in a novel SMEDDS formulation using quality by design (QbD) approach. Processes. 13, 2933 (2025) https://doi.org/10.3390/pr13092933
da Silva LAD, et al. Preparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion. Int. J. Pharm. 541, 1–10 (2018) https://doi.org/10.1016/j.ijpharm.2018.02.020
Maharana RL, Swain S, Mahapatra SK, Jena BR. Self-emulsifying drug delivery systems: Concept to applications, regulatory issues, recent patents, current challenges and future directions. Curr. Pharm. Biotechnol. 26, 341–364 (2024) https://doi.org/10.2174/0113892010296223240612050639
Quodbach J, Preis E, Karkossa F, Winck J, Finke JH, Steiner D. Novel strategies for the formulation of poorly water-soluble drug substances by different physical modification strategies with a focus on peroral applications. Pharmaceutics. 17, 1089 (2025) https://doi.org/10.3390/ph18081089
Dhavalkumar M, et al. Role of polymeric carriers in amorphous solid dispersions: Comprehensive review of stabilization mechanisms, dissolution behavior, and FDA-approved formulations. Colloid Polym. Sci. (2026) https://doi.org/10.1007/s00289-026-06309-5
Nikam AP, Meshram PD, Vanjari AV, Mundada SV. Comparative study of spray-drying and freeze-drying techniques for increasing fenofibrate's solubility and dissolution rate. BIO Integration. 5 (2024) https://doi.org/10.15212/bioi-2024-0010
Baek K, Jin SG. Solidification materials and technology for solid self-emulsifying drug delivery systems. Pharmaceutics. 18, 1550 (2025) https://doi.org/10.3390/ph18101550
Prajapati AP, Patel PS, Vadgama NS, Narkhede S, Luhar S, Gandhi SJ. Formulation development and evaluation of solid self-microemulsifying drug delivery system of azelnidipine. Int. J. Pharm. Sci. Drug Res. 15(3), 237–249 (2023) https://doi.org/10.25004/ijpsdr.2023.150303
Mahmoud SH, Ji X, Isse FA. Nimodipine pharmacokinetic variability in various patient populations. Clin. Pharmacokinet. 59, 1463–1483 (2020) https://doi.org/10.1007/s40268-020-00322-3
Pereira JA, Diniz LF, Lehmann CW, Carvalho PS. Pharmaceutical salts of carvedilol with increased solubility as an approach for enhancing the drug action. Cryst. Growth Des. 24(9), 6658–6672 (2024) https://doi.org/10.1021/acs.cgd.4c00547
Boopathi RS, Sankararajan U, Ezhilarasan. A paradigm shift in bioavailability enhancement using solid self-emulsifying drug delivery system. J. Appl. Pharm. Res. 13(1), 14–24 (2025) https://doi.org/10.69857/joapr.v13i1.704
Friedl JD, Jörgensen AM, Le-Vinh B, Braun DE, Tribus M, Bernkop-Schnürch A. Solidification of self-emulsifying drug delivery systems (SEDDS): Impact on storage stability of a therapeutic protein. J. Colloid Interface Sci. 584, 684–697 (2021) https://doi.org/10.1016/j.jcis.2020.11.051
Muhammed SA, Al-Kinani KK. Formulation and in vitro evaluation of meloxicam as a self-microemulsifying drug delivery system. F1000Research 12, 130749 (2023) https://doi.org/10.12688/f1000research.130749.2
Hwang SJ, et al. Development of a self-microemulsifying drug delivery system using dunnione to enhance bioavailability. J. Pharm. Investig. 54(5), 605–615 (2024) https://doi.org/10.1007/s40005-024-00672-z
Kale SS, Kulkarni D, Magar AG, Butle SR, Chalikwar SS, Moravkar KK. SeDeM and powder flow tools-assisted design of solid SMEDDS of luliconazole for antifungal therapy. Ther. Deliv. (2026) https://doi.org/10.1080/20415990.2026.2633965
Bourderi-Cambon A, et al. Improving in vitro–in vivo correlation (IVIVC) for lipid-based formulations: Overcoming challenges and exploring opportunities. Pharmaceutics 17, 1310 (2025) https://doi.org/10.3390/pharmaceutics17101310
Kovacevic M, Gasperlin M, Pobirk AZ. Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and/or lower its dose: A review. Acta Pharm. 74(2), 201–227 (2024) https://doi.org/10.2478/acph-2024-0023
Tuntiyasawasdikul S, Somintara S, Mekjaruskul C, Tabboon P, Areemit J, Sripanidkulchai B. Pharmacokinetic and toxicological assessment of a solid self-microemulsifying drug delivery system (S-SMEDDS) of Kaempferia parviflora in rats. J. Drug Deliv. Sci. Technol. 99, 105955 (2024) https://doi.org/10.1016/j.jddst.2024.105955
Omachi Y. Gastroretentive sustained-release tablets combined with a solid self-micro-emulsifying drug delivery system adsorbed onto Fujicalin®. AAPS PharmSciTech 23, 311 (2022) https://doi.org/10.1208/s12249-022-02311-y
Aswathy SR, Elango H. Optimization of green LC-MS method for rosuvastatin and teneligliptin using AQbD chemometric approach. J. Appl. Pharm. Res. 13(5), 47–59 (2025) https://doi.org/10.69857/joapr.v13i5.1415
Suram D, Veerabrahma K. Design and development of solid SMEDDS and liquisolid formulations of lovastatin for improved drug dissolution and in vivo effects—A pharmacokinetic and pharmacodynamic assessment. AAPS PharmSciTech 23, 272 (2022) https://doi.org/10.1208/s12249-022-02272-2
Madhav KV, Kishan V. Improvement of anti-hyperlipidemic activity and oral bioavailability of fluvastatin via solid self-microemulsifying systems and comparison with liquisolid formulation. Curr. Drug Deliv. 15(9), 1245–1260 (2018) https://doi.org/10.2174/1567201815666180723115141
Silberstein S, Spierings ELH, Kunkel T. Celecoxib oral solution and the benefits of self-microemulsifying drug delivery systems (SMEDDS) technology: A narrative review. Drugs 83(16), 1503–1515 (2023) https://doi.org/10.1007/s40122-023-00529-7
Li ZL, et al. Solid self-microemulsifying drug delivery system for improved oral bioavailability of relugolix: Preparation and evaluation. Int. J. Nanomedicine 20, 1065–1082 (2025) https://doi.org/10.2147/IJN.S497099
Kumar RS, Sureshkumar R. A review on solid supersaturable SNEDDS. Res. J. Pharm. Technol. 13(12), 6219–6226 (2020) https://doi.org/10.5958/0974-360X.2020.00625.3
Sahu KK, Tripathi N, Agarwal N, Swami U. Relugolix in the management of prostate cancer. Expert Rev. Anticancer Ther. 22(9), 891–902 (2022) https://doi.org/10.1080/14737140.2022.2105209
Kadu PJ, Kushare SS, Thacker DD, Gattani SG. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm. Dev. Technol. 16(1), 65–74 (2011) https://doi.org/10.3109/10837450903499333
Shin DJ, et al. Improved dissolution and oral bioavailability of valsartan using a solidified supersaturable self-microemulsifying drug delivery system containing Gelucire® 44/14. Pharmaceutics 11(2), 58 (2019) https://doi.org/10.3390/pharmaceutics11020058
Thota SK, Dudhipala N, Katla V, Veerabrahma K. Cationic solid SMEDDS of efavirenz for improved oral delivery: Development by central composite design, in vitro and in vivo evaluation. AAPS PharmSciTech 24, 53 (2023) https://doi.org/10.1208/s12249-022-02495-3
Arif SA, Mitchell MM. Iloperidone: A new drug for the treatment of schizophrenia. Am. J. Health Syst. Pharm. 68(4), 301–308 (2011) https://doi.org/10.2146/ajhp100079
Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 70(2), 439–444 (2008) https://doi.org/10.1016/j.ejpb.2008.05.001
Baghel P, Roy A, Verma S, Satapathy T, Bahadur S. Amelioration of lipophilic compounds in regards to bioavailability as self-emulsifying drug delivery system (SEDDS). Future J. Pharm. Sci. 6, 42 (2020) https://doi.org/10.1186/s43094-020-00042-0
Kim MS, Ha ES, Choo GH, Baek IH. Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system. Int. J. Mol. Sci. 16(5), 10821–10833 (2015) https://doi.org/10.3390/ijms160510821
Sai LS, Dasankoppa FS, Mutalik S, Pisay M. Hot melt extrusion aided amorphous solid dispersions of quercetin and resveratrol for solubility enhancement. J. Appl. Pharm. Res. 13(1), 25–37 (2025) https://doi.org/10.69857/joapr.v13i1.734
Adepu S, Ramakrishna S. Controlled drug delivery systems: Current status and future directions. Molecules 26(19), 5905 (2021) https://doi.org/10.3390/molecules26195905
Al-Kandari BM, Al-Soraj MH, Hedaya MA. Dual formulation and interaction strategies to enhance the oral bioavailability of paclitaxel. J. Pharm. Sci. 109(11), 3386–3393 (2020) https://doi.org/10.1016/j.xphs.2020.07.027
Alghaith AF, et al. Dissolution enhancement of gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation. Saudi Pharm. J. 32, 102070 (2024) https://doi.org/10.1016/j.jsps.2024.102070
Scheen AJ. Pharmacodynamics, efficacy and safety of sodium-glucose cotransporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus. Drugs 75(1), 33–59 (2015) https://doi.org/10.1007/s40265-014-0337-y
Mudyahoto TR, Omoteso OA, Khamanga SM, Walker RB. Formulation development and optimization of artemether-lumefantrine self-nanoemulsifying drug delivery systems. Pharmazie 80(8), 39–50 (2025) https://doi.org/10.1691/ph.2025.5008
Adams SP, Sekhon SS, Wright JM. Lipid-lowering efficacy of rosuvastatin. Cochrane Database Syst. Rev. 11, CD010254 (2014) https://doi.org/10.1002/14651858.CD010254.pub2
Ying J, Du LD, Du GH. Lovastatin. In: Natural Small Molecule Drugs from Plants. Springer, Singapore, 93–100 (2018) https://doi.org/10.1007/978-981-10-8022-7_15
Lakumalla D, Podichety N, Maddali R. Design and characterization of glimepiride hydrotropic solid dispersion to enhance the solubility and dissolution. J. Appl. Pharm. Res. 12(2), 68–78 (2024) https://doi.org/10.18231/j.joapr.2024.12.2.68.78
Tang S, et al. Screening Ganoderma lucidum spore oil-based oral solid self-microemulsion of paclitaxel for enhanced chemotherapeutic efficacy via immunomodulation in colorectal cancer. J. Drug Deliv. Sci. Technol. 113, 107419 (2025) https://doi.org/10.1016/j.jddst.2025.107419
Ni XL, et al. In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer. Drug Deliv. 24(1), 1501–1512 (2017) https://doi.org/10.1080/10717544.2017.1384862
Kaushal S, Singh H, Thangaraju P, Singh J. Canagliflozin: A novel SGLT2 inhibitor for type 2 diabetes mellitus. N. Am. J. Med. Sci. 6(3), 107–113 (2014) https://doi.org/10.4103/1947-2714.128471
El-Darzi N, et al. Low-dose anti-HIV drug efavirenz mitigates retinal vascular lesions in a mouse model of Alzheimer's disease. Front. Pharmacol. 13, 902254 (2022) https://doi.org/10.3389/fphar.2022.902254
Mendez R, et al. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral. Clin. Ther. 21(1), 160–171 (1999) https://doi.org/10.1016/S0149-2918(00)88276-4
Tao C, Huo T, Zhang M, Chen Z, Zhang X, Song H. Evaluation of the stability and absorption of tacrolimus self-microemulsifying drug delivery system: In vitro/In vivo evaluation of FK506-SMEDDS. J. Drug Deliv. Sci. Technol. 57, 101640 (2020) https://doi.org/10.1016/j.jddst.2020.101640
Fan W, Zhang X, Zhu W, Zhang X, Di L. Preparation of curcumin-Eudragit® EPO solid dispersions with gradient temperature through hot-melt extrusion. Molecules 26(16), 4964 (2021) https://doi.org/10.3390/molecules26164964
Gan Y, et al. Supersaturation and precipitation applicated in drug delivery systems: Development strategies and evaluation approaches. Molecules 28(5), 2212 (2023) https://doi.org/10.3390/molecules28052212
Krstić M, Medarević Đ, Đuriš J, Ibrić S. Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs. In: Lipid Nanocarriers for Drug Targeting. Elsevier, 473–508 (2018) https://doi.org/10.1016/B978-0-12-813687-4.00012-8
Basem Y, Ata A, Sabry F, Tamer M, Raaft E, Abdelmonem R. Sustainable green polymer production for pharmaceutical manufacturing: A review of environmental and economic impacts. Polymers 18(7), 842 (2026) https://doi.org/10.3390/polym18070842
Published
How to Cite
Issue
Section
Copyright (c) 2026 P. R. Kaple, S. S. Agarwal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
